Jing Hao

Shandong University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index3.2kcitations186works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(44), Breast Lesions and Carcinomas(22), Advanced Radiotherapy Techniques(19), Breast Implant and Reconstruction(14), RNA modifications and cancer(13)

Publications185 total

MZF1-AS1/NSUN2 promotes the peritoneal metastasis of gastric cancer by enhancing the stability of RAB13 mRNA
Gastric Cancer·2025
Supplementary Tables 1-3, Figures 1-3 from Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
2025Open Access
VSA012, a CFB-targeted siRNA, demonstrates a favorable safety profile and sustained efficacy in PNH patients: Interim Analysis from a Phase Ib Study
Blood·2025Open Access
Nab-paclitaxel plus bevacizumab for patients with metastatic extrapulmonary neuroendocrine carcinoma: a phase 2 single-arm study
EClinicalMedicine·2025· 2 citedOpen Access
177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial
Annals of Oncology·2025Open Access
Catechol‐Bonded Universal Flash Coating toward Liquid‐Like Surfaces
Advanced Functional Materials·2025
A recurrence risk score model evaluating effects of postmastectomy radiotherapy in breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy: a multicenter, retrospective study
Therapeutic Advances in Medical Oncology·2025Open Access
Dose-Volume Predictors for Radiation Esophagitis in Breast Cancer Patients Undergoing Conventional Fractionated Regional Nodal Radiotherapy: A Prospective Study
International Journal of Radiation Oncology*Biology*Physics·2025
559P SHR-A1921, a novel trophoblast cell-surface antigen 2 targeted antibody-drug conjugate, with or without adebrelimab in advanced triple-negative breast cancer (TNBC): Data from two open-label, multicenter clinical trials
Annals of Oncology·2025
Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients
Frontiers in Immunology·2025Open Access
[Correlation Analysis of Inflammatory Indexes and Bone Marrow Cytological Characteristics with Prognosis in Patients with Hemophagocytic Lymphohistiocytosis].
PubMed·2025
Detecting biliary complications following liver transplantation with contrast-enhanced ultrasound
World Journal of Radiology·2025· 1 citedOpen Access
The State as a Catalyst: How Government-Initiated Social Program Boosts Firm Performance?
Economic Analysis and Policy·2025
[Clinical Characteristics and Prognostic Analysis of Peripheral T-Cell Lymphoma, Not Otherwise Specified].
PubMed·2025
2654 Neoadjuvant Chemoradiotherapy with Simultaneous Integrated Boost for Stage II/III Rectal Adenocarcinoma: 9-year Outcomes of a Phase II Study
Radiotherapy and Oncology·2025
837 Preoperative Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer: Phase II Results of STELLAR II
Radiotherapy and Oncology·2025· 3 cited
An upfront patient selection strategy based on personalized data-driven computed tomography generation for deep inspiration breath-hold in breast radiotherapy
Physica Medica·2025· 1 cited
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery
Clinical and Translational Radiation Oncology·2025· 2 citedOpen Access
Abstract CT084: Prediction of surufatinib treatment outcome in advanced grade 3 neuroendocrine tumors (NET G3) patients
Cancer Research·2025
Risk factors for the delayed discharge from anesthesia intensive care unit: a single-center retrospective study
BMC Anesthesiology·2025Open Access
page 1 of 10Next →

Frequent Co-authors

Ye‐Xiong Li(10), Shulian Wang(8), Jing Jin(7), Yu Tang(7), Ruihong Zhang(6), Jianyang Wang(6), Xiaoli Zhang(6), Qing Gao(5), Hui Fang(5), Yong Yang(5), Yuan Tang(5), Yong-Wen Song(5), Hua Ren(4), Jinhao Sun(4), Yue‐Ping Liu(4), Xiaoxia Qi(3), Dexiao Zhu(3), Bo Chen(3), Weihu Wang(3), Yulan Mu(3)